{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:54:34Z","timestamp":1781542474766,"version":"3.54.5"},"reference-count":41,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Ruling out advanced fibrosis\/cirrhosis is mandatory for persons with hemophilia (PWH) who are candidates for gene therapy. However, clinical evaluation and noninvasive tests (NITs) may be inaccurate after hepatitis C virus (HCV) clearance. We conducted a prospective hepatological screening to detect advanced fibrosis\/cirrhosis in PWH after HCV clearance. Any risk factor of chronic liver damage was registered by using biochemical data, liver stiffness measurement (LSM), and ultrasound (US). A pre\/post-HCV clearance analysis was conducted prospectively in a subgroup of patients who underwent LSM, US, and NITs for fibrosis. We evaluated 119 patients (median age, 53 years; range, 36-87 years) with a previous HCV infection (hemophilia A, n\u00a0= 108; hemophilia B, n\u00a0= 11). Ninety-six (81%) presented at least 1 potential risk factor of chronic liver damage. Metabolic risk factors were the most prevalent, with 51 patients (44%) having US steatosis. In 21 patients (18%), clinical, biochemical, liver morphology, and\/or LSM were suggestive of advanced fibrosis\/cirrhosis. Furthermore, 10 patients (8%) had esophageal varices and 3 (3%) had hepatocellular carcinoma. In 57 patients included in the prospective analysis, LSM and NITs were reduced after HCV clearance (P\u00a0&amp;lt; .05), but US signs specific of cirrhosis remained unchanged. Overall, 23 of 80 patients (29%) with LSM &amp;lt;10 KPa had at least 1 US sign suggestive of advanced fibrosis\/cirrhosis. A similar proportion (18%) was observed for LSM &amp;lt;8 KPa. Overall, risk factors of chronic liver damage are frequent after HCV clearance, but changes in LSM and NITs after clearance may be inaccurate to rule out advanced fibrosis\/cirrhosis. A specific diagnostic workup is warranted to evaluate liver health in PWH in the era of gene therapy.<\/jats:p>","DOI":"10.1182\/bloodadvances.2023010723","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T14:04:44Z","timestamp":1690553084000},"page":"5817-5824","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":15,"title":["Residual burden of liver disease after HCV clearance in hemophilia: a word of caution in the era of gene therapy"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4685-7184","authenticated-orcid":false,"given":"Vincenzo","family":"La Mura","sequence":"first","affiliation":[{"name":"1Foundation Istituto di Ricovero e Cura a Carattere Scientifico Ca\u2019 Granda, Ospedale Maggiore Policlinico-Angelo Bianchi Bonomi and Thrombosis Center, Milan, Italy"},{"name":"2Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5667-6857","authenticated-orcid":false,"given":"Niccol\u00f2","family":"Bitto","sequence":"additional","affiliation":[{"name":"1Foundation Istituto di Ricovero e Cura a Carattere Scientifico Ca\u2019 Granda, Ospedale Maggiore Policlinico-Angelo Bianchi Bonomi and Thrombosis Center, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9949-835X","authenticated-orcid":false,"given":"Cecilia","family":"Capelli","sequence":"additional","affiliation":[{"name":"1Foundation Istituto di Ricovero e Cura a Carattere Scientifico Ca\u2019 Granda, Ospedale Maggiore Policlinico-Angelo Bianchi Bonomi and Thrombosis Center, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9205-2873","authenticated-orcid":false,"given":"Camilla","family":"Caputo","sequence":"additional","affiliation":[{"name":"1Foundation Istituto di Ricovero e Cura a Carattere Scientifico Ca\u2019 Granda, Ospedale Maggiore Policlinico-Angelo Bianchi Bonomi and Thrombosis Center, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Siboni","sequence":"additional","affiliation":[{"name":"1Foundation Istituto di Ricovero e Cura a Carattere Scientifico Ca\u2019 Granda, Ospedale Maggiore Policlinico-Angelo Bianchi Bonomi and Thrombosis Center, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5743-9098","authenticated-orcid":false,"given":"Sara","family":"Arcudi","sequence":"additional","affiliation":[{"name":"1Foundation Istituto di Ricovero e Cura a Carattere Scientifico Ca\u2019 Granda, Ospedale Maggiore Policlinico-Angelo Bianchi Bonomi and Thrombosis Center, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Ciavarella","sequence":"additional","affiliation":[{"name":"1Foundation Istituto di Ricovero e Cura a Carattere Scientifico Ca\u2019 Granda, Ospedale Maggiore Policlinico-Angelo Bianchi Bonomi and Thrombosis Center, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6465-7624","authenticated-orcid":false,"given":"Roberta","family":"Gualtierotti","sequence":"additional","affiliation":[{"name":"1Foundation Istituto di Ricovero e Cura a Carattere Scientifico Ca\u2019 Granda, Ospedale Maggiore Policlinico-Angelo Bianchi Bonomi and Thrombosis Center, Milan, Italy"},{"name":"2Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5918-0171","authenticated-orcid":false,"given":"Anna Ludovica","family":"Fracanzani","sequence":"additional","affiliation":[{"name":"2Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy"},{"name":"3Unit of Internal Medicine and Metabolic Diseases, Foundation Istituto di Ricovero e Cura a Carattere Scientifico Ca\u2019 Granda, Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9996-9385","authenticated-orcid":false,"given":"Angelo","family":"Sangiovanni","sequence":"additional","affiliation":[{"name":"4Gastroenterology and Hepatology, Foundation Istituto di Ricovero e Cura a Carattere Scientifico Ca\u2019 Granda, Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7423-9864","authenticated-orcid":false,"given":"Flora","family":"Peyvandi","sequence":"additional","affiliation":[{"name":"1Foundation Istituto di Ricovero e Cura a Carattere Scientifico Ca\u2019 Granda, Ospedale Maggiore Policlinico-Angelo Bianchi Bonomi and Thrombosis Center, Milan, Italy"},{"name":"2Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"issue":"2","key":"2023101012211329200_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1055\/s-0038-1655774","article-title":"Management of HCV-related liver disease in hemophilia and thalassemia","volume":"38","author":"Rumi","year":"2018","journal-title":"Semin Liver Dis"},{"issue":"2","key":"2023101012211329200_bib2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/bjh.17438","article-title":"Viral hepatitis in haemophilia: historical perspective and current management","volume":"195","author":"Isfordink","year":"2021","journal-title":"Br J Haematol"},{"issue":"5","key":"2023101012211329200_bib3","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/liv.14337","article-title":"High rate of sustained virological response with direct-acting antivirals in haemophiliacs with HCV infection: a multicenter study","volume":"40","author":"Mancuso","year":"2020","journal-title":"Liver Int"},{"issue":"4","key":"2023101012211329200_bib4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jhep.2016.05.027","article-title":"Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension","volume":"65","author":"Mandorfer","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"2023101012211329200_bib5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2018.06.010","article-title":"Impact of DAAs on liver transplantation: major effects on the evolution of indications and results. An ELITA study based on the ELTR registry","volume":"69","author":"Belli","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"2023101012211329200_bib6","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jhep.2020.05.050","article-title":"Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension","volume":"73","author":"Lens","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"2023101012211329200_bib7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jhep.2021.09.013","article-title":"Incidence of liver- and nonliver-related outcomes in patients with HCV-cirrhosis after SVR","volume":"76","author":"D\u2019Ambrosio","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"2023101012211329200_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/hepr.13833","article-title":"Impact of sustained viral response for hepatitis C virus on the outcomes of liver transplantation in hemophilic patients with human immunodeficiency virus\/hepatitis C virus co-infection: a nationwide survey in Japan","volume":"53","author":"Hidaka","year":"2023","journal-title":"Hepatol Res"},{"issue":"1","key":"2023101012211329200_bib9","doi-asserted-by":"crossref","first-page":"100545","DOI":"10.1016\/j.aohep.2021.100545","article-title":"The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophilia","volume":"27","author":"Inukai","year":"2022","journal-title":"Ann Hepatol"},{"issue":"5","key":"2023101012211329200_bib10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/hae.14607","article-title":"Prevalence and risk factors for hepatocellular carcinoma in individuals with haemophilia in the era of direct-acting antiviral agents: a national inpatient sample study","volume":"28","author":"Yang","year":"2022","journal-title":"Haemophilia"},{"issue":"Suppl 2","key":"2023101012211329200_bib11","first-page":"S3","article-title":"Treatment outcomes, quality of life, and impact of hemophilia on young adults (aged 18-30 years) with hemophilia","volume":"90","author":"Witkop","year":"2015","journal-title":"Am J Hematol"},{"issue":"6","key":"2023101012211329200_bib12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/hae.13291","article-title":"Prevalence and impact of obesity in people with haemophilia: review of literature and expert discussion around implementing weight management guidelines","volume":"23","author":"Kahan","year":"2017","journal-title":"Haemophilia"},{"issue":"39","key":"2023101012211329200_bib13","doi-asserted-by":"crossref","first-page":"e12551","DOI":"10.1097\/MD.0000000000012551","article-title":"The elevated prevalence of risk factors for chronic liver disease among ageing people with hemophilia and implications for treatment","volume":"97","author":"Qvigstad","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"2023101012211329200_bib14","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII \u2013 renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"2023101012211329200_bib15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"2023101012211329200_bib16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jhep.2022.11.014","article-title":"Liver-related aspects of gene therapy for haemophilia: call to action for collaboration between haematologists and hepatologists","volume":"78","author":"Miesbach","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"2023101012211329200_bib17","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.jtha.2023.04.030","article-title":"Liver-related aspects of gene therapy for haemophilia: need for collaborations with hepatologists","volume":"21","author":"Miesbach","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"2023101012211329200_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jtha.2022.12.029","article-title":"Hemophilia treatment innovation: 50 years of progress and more to come","volume":"21","author":"Mannucci","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"2023101012211329200_bib19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jhep.2013.03.013","article-title":"The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response","volume":"59","author":"D\u2019Ambrosio","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"2023101012211329200_bib20","unstructured":"EpiCentro. Indicatori Passi: consumo di bevande alcoliche. Accessed 7 August 2023. https:\/\/www.epicentro.iss.it\/passi\/indicatori\/alcol#:\u223c:text=Passi%20misura%20il%20consumo%20di,gradazioni%20tipiche%20di%20queste%20bevande."},{"issue":"6","key":"2023101012211329200_bib21","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of nonalcoholic fatty liver disease","volume":"64","author":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO)","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"2023101012211329200_bib22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on noninvasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update","volume":"75","author":"European Association for the Study of the Liver Electronic address easloffice@easlofficeeu","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"2023101012211329200_bib23","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/liv.13888","article-title":"Multimodality treatment of hepatocellular carcinoma: how field practice complies with international recommendations","volume":"38","author":"Sangiovanni","year":"2018","journal-title":"Liver Int"},{"issue":"3","key":"2023101012211329200_bib24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"2023101012211329200_bib25","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/17474086.2022.2144217","article-title":"Rational hemostatic management in cirrhosis: from old paradigms to new clinical challenges","volume":"15","author":"La Mura","year":"2022","journal-title":"Expert Rev Hematol"},{"issue":"Suppl 6","key":"2023101012211329200_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the management of hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"issue":"5","key":"2023101012211329200_bib27","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: final update of the series\u2606","volume":"73","author":"European Association for the Study of the Liver Electronic address easloffice@easlofficeeu","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"2023101012211329200_bib28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"2023101012211329200_bib29","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/liv.15559","article-title":"Carvedilol as the new nonselective beta-blocker of choice in patients with cirrhosis and portal hypertension","volume":"43","author":"Turco","year":"2023","journal-title":"Liver Int"},{"issue":"3","key":"2023101012211329200_bib30","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"2023101012211329200_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2022.08.030","article-title":"Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease","volume":"78","author":"\u00c5berg","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"Suppl 1","key":"2023101012211329200_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jth.15189","article-title":"Mortality in congenital hemophilia A - a systematic literature review","volume":"19","author":"Hay","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"11","key":"2023101012211329200_bib33","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/obr.12746","article-title":"Obesity in the global haemophilia population: prevalence, implications and expert opinions for weight management","volume":"19","author":"Wilding","year":"2018","journal-title":"Obes Rev"},{"key":"2023101012211329200_bib34","doi-asserted-by":"crossref","first-page":"10760296221128294","DOI":"10.1177\/10760296221128294","article-title":"Prevalence of nonalcoholic fatty liver disease and associated factors in patients with moderate or severe hemophilia: a multicenter-based study","volume":"28","author":"Shen","year":"2022","journal-title":"Clin Appl Thromb"},{"issue":"10","key":"2023101012211329200_bib35","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.14309\/ajg.0000000000000340","article-title":"Alcohol consumption and risk of liver cirrhosis: a systematic review and meta-analysis","volume":"114","author":"Roerecke","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"2023101012211329200_bib36","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"2023101012211329200_bib37","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2020.03.030","article-title":"Undefined\/nonmalignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis","volume":"73","author":"Sangiovanni","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"2023101012211329200_bib38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/hae.14668","article-title":"Liver-related complications before and after successful treatment of chronic hepatitis C virus infection in people with inherited bleeding disorders","volume":"29","author":"Isfordink","year":"2023","journal-title":"Haemophilia"},{"issue":"10","key":"2023101012211329200_bib39","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/cid\/ciy951","article-title":"Post\u2013sustained virologic response liver stiffness may underestimate fibrosis after direct acting antiviral-containing therapy","volume":"68","author":"Kardashian","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2023101012211329200_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1155\/2011\/954812","article-title":"Noninvasive diagnostic and prognostic evaluation of liver cirrhosis and portal hypertension","volume":"31","author":"Berzigotti","year":"2011","journal-title":"Dis Markers"},{"key":"2023101012211329200_bib41","doi-asserted-by":"crossref","first-page":"101011","DOI":"10.1016\/j.blre.2022.101011","article-title":"Progress, and prospects in the therapeutic armamentarium of persons with congenital hemophilia. defining the place for liver-directed gene therapy","volume":"58","author":"Di Minno","year":"2023","journal-title":"Blood Rev"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/19\/5817\/2083554\/blooda_adv-2023-010723-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/19\/5817\/2083554\/blooda_adv-2023-010723-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T12:21:47Z","timestamp":1696940507000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/19\/5817\/497119\/Residual-burden-of-liver-disease-after-HCV"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":41,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2023,10,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010723","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]}}}